- The Argus II is the only retinal implant to have been approved for sale in the European Economic Area, the US, and Canada.
- The California base Second Sight has developed Argus II which costs about $145,000. It is very costly to be brought in local markets yet but it is very promising.
- The Argus II is specifically designed to treat people with retinitis pigmentosa.[4] The device was approved with data from a...
- Figure 1: The Argus II Retinal Prosthesis System, components of the implant (courtesy of Second Sight Medical Products).
- In Europe, the Argus II, as well as the Alpha IMS (Retinal Implant AG), a light-sensitive subretinal implant, have received the CE mark.
- In February 2013, the U.S. Food & Drug Administration (FDA) approved Argus II under a Humanitarian Device Exemption.
- fda'in geçtiğimiz aylarda kulanımına izin verdiği ve 20.000 hastanın sıra beklemeye başladığı uygulama. bu da argus ii'nin uygulandığı yedinci hasta. http...
- The Argus II is a retinal prosthesis device developed by Second Sight Medical Products, designed for individuals with retinitis pigmentosa, a condition...
- Bazı durumlarda, Argus II, görme engelli kullanıcıların büyük harflerle yazılmış harfleri okumasına izin verecek kadar yeterli görüşü geri getirebilir.
Argus II
Электронный имплантат сетчатки